NEW YORK, Sept. 30 - Venture capitalists turned their backs on privately held genomics companies during the third quarter as private-equity markets sought solace among drug discoverers and developers, according to an industry report.
...and receive Daily News bulletins.
Already have a GenomeWeb or 360Dx account?Login Now.
The United Nations is to consider a ban on field testing gene drives at a meeting being held next week, Technology Review reports.
The Associated Press reports that gene-edited food may soon be for sale.
The US Department of Health and Human Services is beginning a series of meetings on human fetal tissue research, Stat News reports.
In Cell this week: epigenetic change linked to glioblastomas, rare and low-frequency variants contributing to multiple sclerosis risk, and more.